Emerald Advisers’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-25,572
Closed -$356K 270
2018
Q2
$356K Sell
25,572
-779
-3% -$13.2K 0.01% 222
2018
Q1
$404K Sell
26,351
-7,190
-21% -$103K 0.02% 217
2017
Q4
$386K Sell
33,541
-2,167
-6% -$32.3K 0.01% 211
2017
Q3
$679K Buy
35,708
+8,427
+31% +$173K 0.03% 192
2017
Q2
$657K Sell
27,281
-11,336
-29% -$249K 0.03% 183
2017
Q1
$765K Sell
38,617
-1,082
-3% -$24.2K 0.03% 192
2016
Q4
$956K Sell
39,699
-208,958
-84% -$5.82M 0.04% 187
2016
Q3
$6.91M Sell
248,657
-77,146
-24% -$2.04M 0.31% 115
2016
Q2
$7.95M Sell
325,803
-62,998
-16% -$1.79M 0.38% 93
2016
Q1
$13.1M Sell
388,801
-54,733
-12% -$1.72M 0.64% 58
2015
Q4
$13.3M Sell
443,534
-26,271
-6% -$885K 0.63% 58
2015
Q3
$14.8M Sell
469,805
-190,852
-29% -$9.31M 0.77% 33
2015
Q2
$32M Sell
660,657
-67,543
-9% -$2.85M 1.52% 3
2015
Q1
$27.3M Buy
728,200
+37,122
+5% +$1.33M 1.37% 8
2014
Q4
$18.2M Buy
691,078
+117,341
+20% +$2.57M 0.96% 24
2014
Q3
$10.2M Buy
573,737
+154,072
+37% +$3.15M 0.6% 50
2014
Q2
$10.1M Sell
419,665
-10,024
-2% -$203K 0.57% 57
2014
Q1
$10.8M Buy
429,689
+72,920
+20% +$2.02M 0.61% 50
2013
Q4
$8.12M Buy
356,769
+45,699
+15% +$923K 0.44% 77
2013
Q3
$7.04M Buy
+311,070
New +$7.18M 0.4% 83

Other funds holding PGEN

Emerald Advisers's PGEN Position: Q3 2018 in Review

Emerald Advisers sold out of Precigen (PGEN) in Q3 2018, closing a stake of 25,572 shares — an estimated $356K sold.

Emerald Advisers first reported a position in PGEN in Q3 2013 and held it in 20 quarters. The position peaked at $32M in Q2 2015. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2018.

  • Emerald Advisers reported no remaining Precigen position as of Q3 2018 after selling out during the quarter.
  • Emerald Advisers sold 25,572 Precigen shares in Q3 2018, an estimated $356K.
  • Emerald Advisers first reported a position in Precigen in Q3 2013 and held it in 20 quarters.
  • Emerald Advisers's Precigen position peaked at $32M in Q2 2015.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2018.

Based on Emerald Advisers's 13F filing for Q3 2018, filed 31 Oct 2018.